Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to prevent bedsores in kids with darker skin

NCT ID NCT07303569

Prevention Sponsor: Nottingham University Hospitals NHS Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study works to prevent pressure injuries (bedsores) in hospitalized children and young people up to age 19. Researchers will improve a risk assessment tool to work better for those with dark skin tones. About 542 participants across 10 UK hospitals will help test the updated tool. The goal is to catch risk early and prevent sores for all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 542 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Phase 1: Healthcare professionals who look after infants, children and young people in hospital (children's nurses and doctors from various clinical areas, dermatologist, tissue viability practitioners and clinical educators); parents/ guardians of children who have a dark skin tone, have developed a pressure injury(s) while in hospital before, and children and young people with dark skin tones who have developed pressure injury(s) while in hospital before. Phase 2: Children and young people with dark skin tone admitted to hospital.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Phase 1 HCP participants: 1. Experts (e.g. tissue viability practitioners, dermatologist) 2. HCP looking after hospitalised infants and CYP 3. Able to give consent Parent/ guardian participants: 1. Parents/ guardians of infants and CYP admitted to hospital with or developed PI 2. Parent/ guardian of a CYP under 19 years of age with dark skin tone according to Fitzpatrick Classification of Skin Types III, IV, V or VI. 3. Able to give consent CYP participants: 1. Age 10 - 19 2. Dark skin tone according to Fitzpatrick Classification of Skin Types III, IV, V or VI. 3. Able to gain consent 4. Able to provide assent with parental consent 5. Developed PI during hospitalisation Phase 2 Hospitalised infants and CYP participants 1\. Infants and CYP admitted to hospital for 24 hrs 2. Age 0-19 years 3. Able to gain consent. 4. Fitzpatrick Classification of Skin Types IV, V or VI. Exclusion Criteria: Phase1: HCP participants: 1. HCP not working with hospitalised infants and CYP. 2. Unable to provide consent. Parents participants: 1. Parents of hospitalised infants and CYP with no PI. 2. Unable to gain consent CYP participants: 1. Not able to provide consent 2. CYP with no PI during hospitalisation period Phase 2 1\. Admitted to hospital for less than 24 hrs 2. Unable to gain consent 3. Fitzpatrick Classification of Skin Types I, II or III

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pressure injuries are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

decubitus ulcer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pressure injuries Pressure ulcers, bedsores, decubitus ulcer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nottingham University Hospital

    RECRUITING

    Nottingham, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.